Immunosuppressant drug (ISD) monitoring is an essential and important requirement for successful organ transplant management. With new products and applications becoming available and technologies constantly evolving, how can you be sure that your knowledge is up-to-date?
Learn more at the 12th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) workshop, "Optimizing Patient Management: Moving ISD Monitoring Forward," sponsored by Siemens Healthcare Diagnostics.
During this workshop attendees will learn what thought-leaders in the field are saying about new solutions for monitoring Mycophenolic Acid (MPA) levels in transplant patients and new strategies for Bayesian estimation and dose adjustments for MPA therapy. Additionally, gain insight into future solutions for ISD testing from Siemens.
Source: Siemens Healthcare
